Association between education level and HIV-associated neurocognitive disorder: a systematic review and meta-analysis
Bozhi Liu A and Wei Li
A B
+ Author Affiliations
- Author Affiliations
A Cancer Center, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshundong Street, Chaoyang District, Beijing 100015, China.
B Corresponding author. Email: vision988@126.com
Sexual Health 17(6) 475-484 https://doi.org/10.1071/SH20057
Submitted: 9 April 2020 Accepted: 23 June 2020 Published: 21 December 2020
Abstract
In the era of antiretroviral treatment, human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) is common in HIV-positive (HIV+) patients, with an incidence of 30–50%. The relationship between education level and HAND has been evaluated in some studies, however, the results were inconsistent. The aim of this meta-analysis was to provide compelling evidence on the association between education level and the risk of HAND. Reports were searched for in the databases of Medline, Embase and PsyclNFO. Studies evaluating the relationship between education level and HAND in adult HIV+ patients were included. The pooled odds ratio/risk ratio was analysed by using the random-effects model. Two subgroup analyses were performed according to the adjustment of educational level in the neurocognitive impairment assessment and the income level. In total, 18 studies were included. Six studies and 12 studies reported education level as the continuous variable and categorical variable, respectively. The methods used for the assessment of neurocognitive impairment in included studies were neuropsychological battery tests (n = 10), HIV Dementia Scale (n = 1), the International HIV Dementia Scale (n = 6) and the Chinese version of the Montreal Cognitive Assessment (n = 1). The result showed that the risk of HAND in HIV+ patients who have lower education attainment was significantly higher than that in HIV+ patients who have higher education attainment. In conclusion, this meta-analysis demonstrated that HIV+ patients who have low education attainment carry higher risk of developing HAND compared with HIV+ patients who have high education attainment. This study highlighted the importance of early neurological screening for HIV+ patients who have low education level.
Keywords: dementia, human immunodeficiency virus, neurocognitive impairment.
References
[1] Wendelken LA, Valcour V. Impact of HIV and aging on neuropsychological function. J Neurovirol 2012; 18 256–63.| Impact of HIV and aging on neuropsychological function.Crossref | GoogleScholarGoogle Scholar | 22528478PubMed |
[2] De Cock KM, Jaffe HW, Curran JW. The evolving epidemiology of HIV/AIDS. AIDS 2012; 26 1205–13.
| The evolving epidemiology of HIV/AIDS.Crossref | GoogleScholarGoogle Scholar | 22706007PubMed |
[3] Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69 1789–99.
| Updated research nosology for HIV-associated neurocognitive disorders.Crossref | GoogleScholarGoogle Scholar | 17914061PubMed |
[4] Saloner R, Cysique LA. HIV-associated neurocognitive disorders: a global perspective. J Int Neuropsychol Soc 2017; 23 860–9.
| HIV-associated neurocognitive disorders: a global perspective.Crossref | GoogleScholarGoogle Scholar | 29198283PubMed |
[5] Olivier IS, Cacabelos R, Naidoo V. Risk factors and pathogenesis of HIV-associated neurocognitive disorder: the role of host genetics. Int J Mol Sci 2018; 19 3594
| Risk factors and pathogenesis of HIV-associated neurocognitive disorder: the role of host genetics.Crossref | GoogleScholarGoogle Scholar |
[6] Troncoso FT, de Oliveira Conterno L. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population. Rev Soc Bras Med Trop 2015; 48 390–8.
| Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.Crossref | GoogleScholarGoogle Scholar | 26312927PubMed |
[7] Devlin KN, Giovannetti T. Heterogeneity of neuropsychological impairment in HIV infection: contributions from mild cognitive impairment. Neuropsychol Rev 2017; 27 101–23.
| Heterogeneity of neuropsychological impairment in HIV infection: contributions from mild cognitive impairment.Crossref | GoogleScholarGoogle Scholar | 28536861PubMed |
[8] Elbirt D, Mahlab-Guri K, Bezalel-Rosenberg S, Gill H, Attali M, Asher I. HIV-associated neurocognitive disorders (HAND). Isr Med Assoc J 2015; 17 54–9.
| 25739180PubMed |
[9] Wang Z, Zheng Y, Liu L, Shen Y, Zhang R, Wang J, et al High prevalence of HIV-associated neurocognitive disorder in HIV-infected patients with a baseline CD4 count ≤ 350 cells/µL in Shanghai, China. Biosci Trends 2013; 7 284–9.
| 24390367PubMed |
[10] Letendre SL, Ellis RJ, Ances BM, McCutchan JA. Neurologic complications of HIV disease and their treatment. Top HIV Med 2010; 18 45–55.
| 20516524PubMed |
[11] Yusuf AJ, Hassan A, Mamman AI, Muktar HM, Suleiman AM, Baiyewu O. Prevalence of HIV-associated neurocognitive disorder (HAND) among patients attending a tertiary health facility in northern Nigeria. J Int Assoc Provid AIDS Care 2017; 16 48–55.
| Prevalence of HIV-associated neurocognitive disorder (HAND) among patients attending a tertiary health facility in northern Nigeria.Crossref | GoogleScholarGoogle Scholar | 25331222PubMed |
[12] Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, et al Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 2010; 75 1150–8.
| Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study.Crossref | GoogleScholarGoogle Scholar | 20739646PubMed |
[13] Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003; 17 1539–45.
| Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.Crossref | GoogleScholarGoogle Scholar | 12824792PubMed |
[14] Gannon P, Khan MZ, Kolson DL. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 2011; 24 275–83.
| Current understanding of HIV-associated neurocognitive disorders pathogenesis.Crossref | GoogleScholarGoogle Scholar | 21467932PubMed |
[15] Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, et al Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 2004; 56 416–23.
| Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders.Crossref | GoogleScholarGoogle Scholar | 15349869PubMed |
[16] Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med 2011; 19 137–42.
| 22156215PubMed |
[17] Kivipelto M, Mangialasche F, Ngandu T. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol 2018; 14 653–66.
| Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease.Crossref | GoogleScholarGoogle Scholar | 30291317PubMed |
[18] Focà E, Magro P, Motta D, Compostella S, Casari S, Bonito A, et al Screening for neurocognitive impairment in HIV-infected individuals at first contact after HIV diagnosis: the experience of a large clinical center in northern Italy. Int J Mol Sci 2016; 17 434
| Screening for neurocognitive impairment in HIV-infected individuals at first contact after HIV diagnosis: the experience of a large clinical center in northern Italy.Crossref | GoogleScholarGoogle Scholar | 27023519PubMed |
[19] Ding Y, Lin H, Shen W, Wu Q, Gao M, He N. Interaction effects between HIV and aging on selective neurocognitive impairment. J Neuroimmune Pharmacol 2017; 12 661–9.
| Interaction effects between HIV and aging on selective neurocognitive impairment.Crossref | GoogleScholarGoogle Scholar | 28470583PubMed |
[20] Thai TT, Jones MK, Harris LM, Heard RC. Prevalence and correlates of probable HIV-associated dementia in HIV outpatients in Ho Chi Minh City, Vietnam. J Int Assoc Provid AIDS Care 2017; 16 366–75.
| Prevalence and correlates of probable HIV-associated dementia in HIV outpatients in Ho Chi Minh City, Vietnam.Crossref | GoogleScholarGoogle Scholar | 28367733PubMed |
[21] Tsegaw M, Andargie G, Alem G, Tareke M. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia. J Psychiatr Res 2017; 85 37–41.
| Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia.Crossref | GoogleScholarGoogle Scholar | 27821271PubMed |
[22] Haddow LJ, Laverick R, Daskalopoulou M, McDonnell J, Lampe FC, Gilson R, et al Multicenter European prevalence study of neurocognitive impairment and associated factors in HIV positive patients. AIDS Behav 2018; 22 1573–83.
| Multicenter European prevalence study of neurocognitive impairment and associated factors in HIV positive patients.Crossref | GoogleScholarGoogle Scholar | 28144792PubMed |
[23] Grima P, Fabbiani M, Ciccarelli N, Tana M, Farina S, Colafigli M, et al Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. J Infect 2012; 65 439–46.
| Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.Crossref | GoogleScholarGoogle Scholar | 22863903PubMed |
[24] Yakasai AM, Gudaji MI, Muhammad H, Ibrahim A, Owolabi LF, Ibrahim DA, et al Prevalence and correlates of HIV-associated neurocognitive disorders (HAND) in northwestern Nigeria. Neurol Res Int 2015; 2015 486960
| Prevalence and correlates of HIV-associated neurocognitive disorders (HAND) in northwestern Nigeria.Crossref | GoogleScholarGoogle Scholar | 26347017PubMed |
[25] Fan Q, Verhoeven VJ, Wojciechowski R, Barathi VA, Hysi PG, Guggenheim JA, et al Meta-analysis of gene-environment-wide association scans accounting for education level identifies additional loci for refractive error. Nat Commun 2016; 7 11008
| Meta-analysis of gene-environment-wide association scans accounting for education level identifies additional loci for refractive error.Crossref | GoogleScholarGoogle Scholar | 27020472PubMed |
[26] Premi E, Grassi M, van Swieten J, Galimberti D, Graff C, Masellis M, et al Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study. Brain 2017; 140 1784–91.
| Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.Crossref | GoogleScholarGoogle Scholar | 28460069PubMed |
[27] Stern Y, Arenaza-Urquijo EM, Bartres-Faz D, Belleville S, Cantilon M, Chetelat G, et al Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement 2020; 16 1305–11.
| Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance.Crossref | GoogleScholarGoogle Scholar | 30222945PubMed |
[28] McGrath NM, Cooke GS. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 2007; 69 411–13.
| Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa.Crossref | GoogleScholarGoogle Scholar | 17646642PubMed |
[29] Fialho RM, Pereira M, Mendonca N, Ouakinin S. Depressive symptoms and neurocognitive performance among HIV-infected women. Women & Health 2013; 53 117–34.
| Depressive symptoms and neurocognitive performance among HIV-infected women.Crossref | GoogleScholarGoogle Scholar |
[30] Vassallo M, Durant J, Lebrun-Frenay C, Fabre R, Ticchioni M, Andersen S, et al Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation. HIV Med 2015; 16 431–40.
| Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.Crossref | GoogleScholarGoogle Scholar | 25981452PubMed |
[31] Kinai E, Komatsu K, Sakamoto M, Taniguchi T, Nakao A, Igari H, et al Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study. J Neurovirol 2017; 23 864–74.
| Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.Crossref | GoogleScholarGoogle Scholar | 28971376PubMed |
[32] Gascón MRP, Vidal JE, Mazzaro YM, Smid J, Marcusso RMN, Capitão CG, et al Neuropsychological assessment of 412 HIV-infected individuals in Sao Paulo, Brazil. AIDS Patient Care STDS 2018; 32 1–8.
| Neuropsychological assessment of 412 HIV-infected individuals in Sao Paulo, Brazil.Crossref | GoogleScholarGoogle Scholar | 29323557PubMed |
[33] Hindle JV, Martyr A, Clare L. Cognitive reserve in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 2014; 20 1–7.
| Cognitive reserve in Parkinson’s disease: a systematic review and meta-analysis.Crossref | GoogleScholarGoogle Scholar | 24034887PubMed |
[34] Green S, Higgins JPT, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). Copenhagen: The Cochrane Collaboration; 2011.
[35] Hu J, Dong Y, Chen X, Liu Y, Ma D, Liu X, et al Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies. Compr Psychiatry 2015; 61 78–89.
| Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies.Crossref | GoogleScholarGoogle Scholar | 26005111PubMed |
[36] Lawler K, Jeremiah K, Mosepele M, Ratcliffe SJ, Cherry C, Seloilwe E, et al Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana. PLoS One 2011; 6 e17233
| Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.Crossref | GoogleScholarGoogle Scholar | 21365002PubMed |
[37] Atashili J, Gaynes BN, Pence BW, Tayong G, Kats D, O’Donnell JK, et al Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol 2013; 13 86
| Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study.Crossref | GoogleScholarGoogle Scholar | 23855622PubMed |
[38] Bonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy FA, et al Cognitive disorders in HIV-infected patients: are they HIV-related? AIDS 2013; 27 391–400.
| Cognitive disorders in HIV-infected patients: are they HIV-related?Crossref | GoogleScholarGoogle Scholar | 23079813PubMed |
[39] Cross S, Onen N, Gase A, Overton ET, Ances BM. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale. J Neuroimmune Pharmacol 2013; 8 1114–22.
| Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.Crossref | GoogleScholarGoogle Scholar | 24114509PubMed |
[40] Satz P, Morgenstern H, Miller EN, Selnes OA, McArthur JC, Cohen BA, et al Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr 1993; 6 503–11.
| Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the Multicenter AIDS Cohort Study (MACS).Crossref | GoogleScholarGoogle Scholar | 8483113PubMed |
[41] Morgan EE, Woods SP, Smith C, Weber E, Scott JC, Grant I. Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS Behav 2012; 16 2279–85.
| Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND).Crossref | GoogleScholarGoogle Scholar | 22677976PubMed |
[42] Stern RA, Silva SG, Chaisson N, Evans DL. Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol 1996; 53 148–53.
| Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection.Crossref | GoogleScholarGoogle Scholar | 8639064PubMed |
[43] Pereda M, Ayuso-Mateos JL, Gomez Del Barrio A, Echevarria S, Farinas MC, Garcia Palomo D, et al Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychol Med 2000; 30 205–17.
| Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS.Crossref | GoogleScholarGoogle Scholar | 10722191PubMed |
[44] Milanini B, Ciccarelli N, Fabbiani M, Limiti S, Grima P, Rossetti B, et al Cognitive reserve and neuropsychological functioning in older HIV-infected people. J Neurovirol 2016; 22 575–83.
| Cognitive reserve and neuropsychological functioning in older HIV-infected people.Crossref | GoogleScholarGoogle Scholar | 26965299PubMed |
[45] Kaur N, Dendukuri N, Fellows LK, Brouillette MJ, Mayo N. Association between cognitive reserve and cognitive performance in people with HIV: a systematic review and meta-analysis. AIDS Care 2020; 32 1–11.
| Association between cognitive reserve and cognitive performance in people with HIV: a systematic review and meta-analysis.Crossref | GoogleScholarGoogle Scholar | 31084206PubMed |
[46] Waldrop-Valverde D, Nehra R, Sharma S, Malik A, Jones D, Kumar AM, et al Education effects on the International HIV Dementia Scale. J Neurovirol 2010; 16 264–7.
| Education effects on the International HIV Dementia Scale.Crossref | GoogleScholarGoogle Scholar | 20578972PubMed |
